PHARMACEUTICAL FORMULATIONS AND USE THEREOF IN THE PREVENTION OF STROKE, DIABETES AND/OR CONGESTIVE HEART FAILURE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

13673852

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to use of an inhibitor of the renin-anglotensin system (RAS) or a pharmaceutically acceptable derivative thereof, such as ramipril or ramiprilat, in the prevention of stroke, diabetes and/or congestive heart failure (CHF).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AVENTIS PHARMA DEUTSCHLAND GMBHD-65926 FRANKFURT AM MAIN

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bender, Norbert Hofheim, DE 11 9
Dagenais, Gilles St.-Nicholas, CA 10 9
Gerstein, Hertzel Hamilton, CA 21 100
Ljunggren, Anders Molndal, SE 10 31
Rangoonwala, Badrudin Hofheim, DE 10 9
SCHÔLKENS, Bernward Kelkheim, DE 1 0
Yusuf, Salim Carlisle, CA 22 39

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation